Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:55:15 EDT Fri 03 May 2024
Enter Symbol
or Name
USA
CA



News for U:ALIM from 2023-05-04 to 2024-05-03 - 24 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-30 08:00U:ALIMNews ReleaseAlimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update
2024-03-20 08:00U:ALIMNews ReleaseAlimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-19 08:00U:ALIMNews ReleaseAlimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network
2024-03-07 07:30U:ALIMNews ReleaseAlimera Sciences Reports Fourth Quarter and Full Year 2023 Results
2024-02-29 08:00U:ALIMNews ReleaseAlimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update
2024-02-08 08:00U:ALIMNews ReleaseThe UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN ‚ ®
2024-01-04 08:00U:ALIMNews ReleaseAlimera Completes Recruitment for the Synchronicity Study
2024-01-02 08:00U:ALIMNews ReleaseAlimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-12-12 07:30U:ALIMNews ReleaseAlimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-11-08 16:30U:ALIMNews ReleaseAlimera Appoints Maggie A. Pax to Its Board of Directors
2023-10-31 08:00U:ALIMNews ReleaseAlimera Announces Scientific Data Highlighting ILUVIEN ‚ ® To Be Presented at the American Academy of Ophthalmology
2023-10-26 07:00U:ALIMNews ReleaseAlimera Sciences Reports Third Quarter 2023 Results
2023-10-16 08:00U:ALIMNews ReleaseAlimera Sciences to Report Third Quarter 2023 Financial Results on October 26, 2023, and Provide Corporate Update
2023-10-11 08:00U:ALIMNews ReleaseAlimera Announces Multiple Presentations Highlighting ILUVIEN ‚ ® and YUTIQ ‚ ® Data at Retina Society Annual Congress
2023-10-03 08:00U:ALIMNews ReleaseAlimera Sciences Appoints Jason Werner as Chief Operating Officer
2023-09-05 08:00U:ALIMNews ReleaseAlimera Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-10 07:30U:ALIMNews ReleaseAlimera Sciences Reports Second Quarter 2023 Results
2023-08-08 09:16U:ALIMNews ReleaseStonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
2023-08-02 11:44U:ALIMNews ReleaseAlimera Sciences to Report Second Quarter 2023 Financial Results ‚  on August 10, 2023, and Provide Corporate Update
2023-05-24 08:00U:ALIMNews ReleaseAlimera Completes Recruitment for its Landmark NEW DAY Study
2023-05-18 07:00U:ALIMNews ReleaseAlimera Acquires U.S. Commercial Rights to YUTIQ ‚ ®
2023-05-17 16:05U:ALIMNews ReleaseAlimera Sciences to Host Rescheduled Corporate Update Call on Thursday, May 18, 2023, at 8:30am ET
2023-05-15 07:51U:ALIMNews ReleaseAlimera Sciences Reports First Quarter 2023 Results
2023-05-08 08:00U:ALIMNews ReleaseAlimera Sciences to Report First Quarter 2023 Financial Results on May 15, 2023, and Provide Corporate Update